MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Technology Scientific & Technical Instruments

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > FDA APPROVAL

<< Previous

Bullboard Posts

Next >>

Post by SEMYon Dec 01, 2021 1:12pm

311 Views

Post# 34185749

FDA APPROVAL

How can this possibly be taking this long! it's been over 2 years and still nothing.....Has anyone spoke with Company on what maybe holding up approval? I don't get it, this test is one of the best and most accurate on the market, yet we are forced to sit on the sidelines while the Big Boys clean up the market......FM!

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?